Proving Durable Autoimmune Responses Without Lymphodepletion to Expand Safety, Access & Clinical Impact

• Showcasing autoimmune clinical data achieved without lymphodepletion to demonstrate durable responses while improving patient safety and tolerability
• Sharing evolving PK profiles to illustrate sustained persistence and strengthen confidence in non-conditioning approaches
• Evaluating safety outcomes and patient engagement benefits to positioning nonconditioning approaches as an accessible and scalable therapeutic strategy

Speakers:

Daniel Nunez

Senior Director Computational Biology

Cabaletta Bio